Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
1.820
+0.120 (7.06%)
At close: Nov 20, 2024, 4:00 PM
1.800
-0.020 (-1.10%)
After-hours: Nov 20, 2024, 7:31 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $50.06 million as of November 21, 2024. Its market cap has decreased by -33.76% in one year.
Market Cap
50.06M
Enterprise Value
31.46M
1-Year Change
-33.76%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $50.06M, a decrease of -23.85%. That is a compound annual growth rate of -8.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 50.06M | -63.58% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Scientific | 52.40M |
| 111, Inc. | 52.15M |
| Precision BioSciences | 51.94M |
| Kronos Bio | 51.85M |
| Enzo Biochem | 50.78M |
| Cytosorbents | 50.08M |
| LakeShore Biopharma | 49.99M |
| BGM Group | 48.58M |